chanelink logo
CHANELINK
English

Afinum Management acquires significant stakes in two laser companies

1208
2024-08-08 11:35:32
See translation

Recently, Afinum Management, a private equity firm based in Munich, Germany, has acquired a large stake in two laser companies, with the intention of opening up new laser markets by combining the strengths of three parties.

According to media reports, the two companies are ARC Laser in Germany and GNS neo Laser in Israel, and Afinum has agreed with the founders of the two companies that the acquisition of this stake will be part of a deal that will see the three parties invest in the formation of a consolidated leader in medical laser technology, with the founders of the two laser companies making a further investment in the new company. The founders of the two laser companies will make a further investment in the new company.

Angela Thyzel is the founder of ARC Laser, a company that since its establishment in 1996 has focused on the development of high-quality standard lasers for gentle and effective applications in modern medicine, with a portfolio of laser devices for ophthalmology, ENT, general surgery and veterinary medicine, currently used in a wide range of medical surgical procedures.

GNS neo Laser, also a company with advanced medical laser technology, is an expert in endovenous laser ablation, laser devices for anorectal applications, and fiber optics, and was founded by Gil Shapira, and is now a leader in their respective medical laser solutions, which are contributing to significant advances in patient care and treatment outcomes.

The new joint venture, named MedTech Laser Group, will see the two companies collaborate on technology development, sales and marketing, capitalizing on the growing medical laser market and their own deep technological expertise to drive the new company's rapid growth.

The three companies are really targeting the rapidly growing market for ophthalmic and surgical lasers, which is being driven by long-term trends such as the aging of the population, the rising prevalence of related diseases, and advances in laser treatment technology. In addition, Afinum claims to be pursuing further opportunities to expand the company's technology and product portfolio in the future, both organically and through strategic add-on acquisitions.

Source: OFweek

Related Recommendations